Wexler Wallace is currently investigating claims that the popular interstitial cystitis drug Elmiron is linked to severe and potentially permanent vision damage. If you have taken Elmiron and have suffered eye damage you believe is a result, contact us today to discuss filing an Elmiron vision lawsuit.
Pentosan Polysulfate sodium, commonly known as Elmiron, is an oral prescription drug given to patients suffering from bladder pain and discomfort associated with interstitial cystitis (IC). Manufactured by Janssen Pharmaceuticals, the drug was originally approved for sale by the U.S. Food and Drug Administration in 1996. Elmiron remains the only oral medication approved by the FDA to treat IC.
Elmiron Linked to Severe Vision Damage
Current research suggests a link between Elmiron and severe side effects that may result in permanent vision loss, including maculopathy. Maculopathy is a progressive disease of the macula, a central spot of the retina that controls the ability to read, recognize faces, and see fine detail. Maculopathy can severely limit both central and peripheral vision, making it difficult to discern colors, people, or objects. There is no cure for maculopathy, and damage is often irreversible.
Other reported vision loss side effects associated with Elmiron include:
- Pigmentary and Retinal Maculopathy
- Macular Degeneration
- Eye Pain
- Vision Loss
- Blurred or Distorted vision
- Difficulty reading or adjusting to Darkness
Take Action, File an Elmiron Vision Lawsuit Claim
Despite research showing a link between Elmiron and vision loss, updated labeling warning patients of these risks were not added by the manufacturer until June 2020. Plaintiffs in the ongoing Elmiron vision lawsuits claim the manufacturer was aware of the potential harm and failed to disclose the risks to consumers.
If you were prescribed Elmiron and experienced these or similar side effects and would like to discuss filing an Elmiron vision lawsuit, contact Wexler Wallace today by submitting the form on this page.